Dr. Reddy's Laboratories Limited RDY
14.10 USD -0.07 -0.49%
As of Nov 2, 1:57 PM ET
11.36 52-week range 15.67
- YTD
- +0.43%
- 1 year
- +6.09%
- Open
- 14.15
- Prev close
- 14.17
- Mkt cap
- 11.75B
- Vol
- 748.35K
- Avg vol
- 2.92M
- EPS
- 0.36
- P/E
- 39.18
- Div yield
- 0.46%
More statistics
- Low
- 14.05
- High
- 14.17
- Forward P/E
- 21.39
- Beta
- 0.25
- Short ratio
- 8.16
- Inst. own
- 14.93%
- Dividend
- 0.08
- Ex-div date
- Jul 8, 2026
- Earnings
- Jan 22, 2027
- 50-d avg
- 12.50
- 200-d avg
- 13.21
- 1y target
- 14.31
MAX chart
Chart tools
Chart is warming up
The all-time price history for RDY has not been loaded yet. Try again in a moment.
Altman Z-Score
5.53 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 3
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 3
- P/E 2
- P/B 3
P/E 24.0×
P/S 3.0×
P/B 2.9×
P/FCF 33.6×
EV/EBITDA 13.7×
EV/Sales 3.2×
FCF Yield 3.0%
Gross Margin 52.8%
Operating Margin 13.8%
Net Margin 12.8%
ROE 12.2%
ROIC 8.1%
ROA 7.9%
Revenue 8.6%
Operating Income -32.0%
EPS (diluted) -20.4%
Free Cash Flow 166.8%
Current Ratio 1.8×
Quick Ratio 1.3×
Debt / Equity 0.2×
Net Debt / EBITDA 0.7×
Interest Coverage 12.4×
Dividend Yield 0.7%
Payout Ratio 15.5%
Annual · latest fiscal year ends 2026-03-31